로딩 중…
지수 로딩 중…
Syndax Pharmaceuticals, Inc.
SNDX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$19.00-0.21%
2026-06-18
Price Chart
Syndax Pharmaceuticals, Inc.+96.08%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.68B |
| Revenue | $217M |
| Net Income | $-243M |
| Total Assets | $473M |
| Net Assets | $42M |
| Value | |
| P/B | 40.45x |
| P/S | 7.75x |
| FCF Yield | -16.53% |
| Profitability | |
| ROA | -51.46% |
| Op. Margin | -102.93% |
| Revenue Growth | 223.64% |
| Financial Health | |
| Debt Ratio | 1035.62% |
| Total Debt | $345M |
| FCF | $-278M |
| Cash | $131M |
| Current Ratio | 5.47x |
| Performance | |
| 1Y Return | 96.08% |
| 1M Return | -1.86% |
| From 52W High | -25.75% |
| 1Y MDD | -38.30% |
| Trading | |
| Volume | 3,260,040 shares |
| Trading Value | $63M |
| Per Share | |
| EPS | $-3.30 |
| BPS | $0.75 |